th birthday.
The genus Leontopodium (Asteraceae) comprises about 58 species in Asia and Europe with a center of diversity in China bearing 36 species including 18 endemic species [1a] . The current taxonomic revision of the genus prompted us to investigate one of the endemic Chinese species, L. andersonii C. B. Clarke (syn.: L. bonatii Beauverd; L. subulatum (Franchet) Beauverd; L. subulatum var. bonatii (Beauverd) Handel-Mazzetti) in comparison to other already investigated species [1b-1d] .
Since previous investigations of the aerial plant parts of different Leontopodium species [1e] showed a highly comparable metabolite profile, we decided to investigate the root material which afforded, beside several known compounds (isocomene, β-isocomene, leoligin (=[(2S,3R,4R)-4-(3,4-dimethoxybenzyl)-2-(3,4,-dimethoxy-phenyl)tetra-hydro-furan-3-yl]methyl-(2Z)-2-methylbut-2-enoate) and its 5-methoxy-derivative as well as the cumarine obliquin), one new compound 1. of two acetoxy groups at C5 and C9, respectively, and one angeloyl moiety positioned at C1. Localization of the ester groups could be established by HMBC correlations. A further quaternary signal at δ C 193.3 could be assigned to a ketonic function and HMBC contacts indicated substitution at C4. Thus, structure of 1 was deduced as in Figure 1 . The substitution pattern is identical with that of a pair of stereoisomeric bisabolane derivatives of the roots of L. alpinum [2a] . However, 1 shows a higher oxidation level at position C4. Assignments of the relative configurations of carbons 1, 5 and 6 of the cyclohex-2-en-4-on ring are based on multi- For the carvotacetone-derivatives coupling constants of J 1,6 3.0 Hz and J 5,6 12.5 Hz are reported. Coupling constants of J 1,6 (2.0 Hz and 10.0 Hz) and J 5,6 (13.2 Hz) determined for 1 support the 1R*,5S* and 6S* configuration. The relative configuration of C7 and C9 in compound 1 remains to be elucidated.
Since some of the bisabolane derivatives showed a significant inhibition of in vitro leukotriene biosynthesis, 1 was tested by the same test model as described in [1b] . Additionally the substance was tested for a direct inhibition of COX-1 and COX-2. Interestingly the compound showed at a concentration of 50 µM no activity in all test systems. This observation might be related to the substitution at position C4, since derivatives without this substitution showed a pronounced effect. 
Experimental

Extraction and purification:
The ground roots of L. andersonii (980.4 g) were exhaustively macerated with CH 2 Cl 2 (11 x 4.0 L) at RT to give 9.9 g (1.0 %) of a semi-solid brown extract. 8.5 g of this extract was subjected to silica gel CC (99.1 g silica gel 60) using a gradient of petroleum ether and acetone to give 16 fraction. Fraction 7 (eluted with petroleum ether/acetone 95:5; 566.4 mg, 6.69 %) was further fractionated by means of Sephadex LH 20 CC (1.5 x 50 cm) using CH 2 Cl 2 and acetone (85:15, v/v) as mobile phase to give 13 fraction. Fraction 5 (eluted after 250 mL; 55.1 mg, 0.65%) was further separated by preparative TLC (PSC-plate, silica gel 60 F 254 ; 20 x 20 cm, 1 mm layer). The sample was applied in a line of 18 cm and developed to a solvent front of 16 cm with a mixture of toluene:ethyl acetate: aqueous acetic acid (10 %) 7:3:1 (v/v/v). After drying, the plate was monitored in UV 254 and UV 366 . The compound was located at a zone with an R f of 0.49 this was removed and suspended in 100 mL CH 2 Cl 2 after ultra-sonication. After filtration, the solution was evaporated to dryness. To remove the remaining silica gel, the sample was applied to small Sephadex LH 20 column (1 x 50 cm, in acetone) to yield 29.2 mg of 1 (0.35%) as colourless resin. 1739, 1649, 1587, 1453, 1372, 1245, 1154, 1096, 1039, 1018, 993, 945, 892, 849 
